Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Bridgebio Pharma, Inc. Common Stock | BBIO

Daily Technical Analysis of Bridgebio Pharma, Inc. Common Stock

Bridgebio Pharma had a nice pop today and is currently up 4.33% we'll see if the cash keeps flowing in.

Currently BBIO isn't at a clear support/resistance line that seems tradable. Bridgebio Pharma has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. In the near term it might meet some resistance around the $36.33 price point in the near future.


Last analyzed on 2024-02-28

Analyst Ratings for Bridgebio Pharma By Price Target And Rating

BridgeBio Pharma has an overall positive view by the analysts. The current Analysts Sentiment Score is 164.97. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-02-23 Citigroup increased their price target by 9.52% to $46.00. BMO Capital Markets initiated a rating of Market Perform on 2024-01-31 and provided a price target of $37.00. HC Wainwright gave a boost to their price target and moved to $47.00 from $22.00 on 2024-01-29. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-01-22 and they set their price target at $50.00. On 2023-12-08 Wells Fargo & Company initiated their coverage and rated as Overweight and they set their price target at $58.00.Mizuho reiterated a rating of Buy on 2023-08-28 and added a price target of $60.00. JPMorgan Chase & Co. provided a price target decease of -9.52% to $38.00 from $42.00 on 2023-08-17. BTIG Research gave a boost to their price target and moved to $42.00 from $32.00 on 2023-07-18. Raymond James gave a boost to their price target and moved to $46.00 from $29.00 on 2023-07-18. On 2023-07-18 The Goldman Sachs Group increased their price target by 72.41% to $50.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
BBIO164.97119.23-7.83220.66-2.13

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-01-27)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
BBIO0.000.00

Short interest for BridgeBio Pharma

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
BBIO11.62%13.793.6316060000

Social Sentiment for BridgeBio Pharma

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
BBIO

Companies with the highest correlation to BridgeBio Pharma

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
EXAS | Exact Sciences Corp0.813.323.36-7.20-8.23-28.96-5.5524-12.08-16.51-14.27-14706.01-6678.24005.2321
ACCD | Accolade, Inc. Common Sto0.76-2.83-7.35-17.0010.67-26.17-19.48223.361.663.44-10147.54-1970.9501254.61812
DNLI | Denali Therapeutics Inc. 0.755.4623.5129.9712.51-9.66-23.1763-7.50-18.35-25.94176.74-6007.690011.2371
KRTX | Karuna Therapeutics, Inc.0.70.720.080.4352.0468.4361.884174.7238.6648.11-1766.66173.95005.68827
UBER | Uber Technologies, Inc.0.71.923.4119.0439.7871.56140.5267196.0585.83107.02-175.00-35073.17002.46538

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-